Adjuvant treatment of melanoma using placebo or no therapies as control-arm: is it ethically correct?

Melanoma Res. 1999 Oct;9(5):528-9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Cancer Vaccines / therapeutic use*
  • Clinical Trials, Phase II as Topic
  • Disease-Free Survival
  • Ethics, Medical*
  • Humans
  • Immunotherapy*
  • Interferons / administration & dosage
  • Melanoma / mortality
  • Melanoma / therapy*
  • Skin Neoplasms / mortality
  • Skin Neoplasms / therapy*
  • Survival Rate
  • Vaccines, Combined

Substances

  • Adjuvants, Immunologic
  • Cancer Vaccines
  • Vaccines, Combined
  • polyvalent melanoma cell vaccine
  • Interferons